Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Vascular Patches Market, by Material
1.4.2 North America Vascular Patches Market, by End User
1.4.3 North America Vascular Patches Market, by Application
1.4.4 North America Vascular Patches Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Vascular Patches Market
Chapter 4. North America Vascular Patches Market by Material
4.1 North America Biologic Market by Country
4.2 North America Synthetic Market by Country
Chapter 5. North America Vascular Patches Market by End User
5.1 North America Hospitals Market by Country
5.2 North America Ambulatory Surgical Centers Market by Country
Chapter 6. North America Vascular Patches Market by Application
6.1 North America Carotid Endarterectomy Market by Country
6.2 North America Open Repair of Abdominal Aortic Aneurysm Market by Country
6.3 North America Vascular Bypass Surgery Market by Country
6.4 North America Congenital Heart Disease Market by Country
6.5 North America Others Market by Country
Chapter 7. North America Vascular Patches Market by Country
7.1 US Vascular Patches Market
7.1.1 US Vascular Patches Market by Material
7.1.2 US Vascular Patches Market by End User
7.1.3 US Vascular Patches Market by Application
7.2 Canada Vascular Patches Market
7.2.1 Canada Vascular Patches Market by Material
7.2.2 Canada Vascular Patches Market by End User
7.2.3 Canada Vascular Patches Market by Application
7.3 Mexico Vascular Patches Market
7.3.1 Mexico Vascular Patches Market by Material
7.3.2 Mexico Vascular Patches Market by End User
7.3.3 Mexico Vascular Patches Market by Application
7.4 Rest of North America Vascular Patches Market
7.4.1 Rest of North America Vascular Patches Market by Material
7.4.2 Rest of North America Vascular Patches Market by End User
7.4.3 Rest of North America Vascular Patches Market by Application
Chapter 8. Company Profiles
8.1 Edwards Lifesciences Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Acquisition and Mergers:
8.2 Baxter International, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Lemaitre Vascular, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Becton, Dickinson and Company
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.5 Terumo Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Regional Analysis
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.6 Aziyo Biologics, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.7 Getinge AB
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.8 B. Braun Melsungen AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.9 Artivion, Inc. (CryoLife, Inc.)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.10. W. L. Gore & Associates, Inc.
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Acquisition and Mergers:
Unique Offerings 
